CClinicalTrials.gg
CompletedNCT02695069Updated Nov 13, 2017

Efficacy Study of Random Placenta Margin Incision to Treat Complete Placenta Previa

A Phase 2 interventional study of Random Placenta Margin Incision in Complete Placenta Previa, sponsored by Maternal and Child Health Hospital of Foshan. Completed at 1 site in China. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-13.

Sponsored by Maternal and Child Health Hospital of Foshan · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this study is to assess the efficacy of random placenta margin incision for hemorrhage control during cesarean section of complete placenta previa pregnancies.

Read the detailed description

Placenta previa is used to describe a placenta that is implanted over or very near the internal cervical os and the complete placenta previa is defined that the internal os is covered completely by placenta. This obstetric complication is associated with high risks for maternal hemorrhage and emergency peripartum hysterectomy can be the only effective action to take, although it carries many morbidities for the women especially those with low parity. Although, nowadays the obstetrician can diagnose placenta previa before delivery, it is still one of the important causes of maternal mortality. The only safe and appropriate mode of delivery for placenta previa is by cesarean delivery. In the absence of accreta, this can usually be accomplished using a lower segment uterine incision. Because of cutting through the placenta, it is often associated with increased maternal bleeding. In addition, the umbilical cord will be also excessive blood loss when the placenta is transected. Theoretically, random placenta margin incision can effectively avoid the damage of the placenta and reduce the maternal blood loss.

The investigators conduct a prospective study to assess the efficacy of random placenta margin incision for hemorrhage control during cesarean section of complete placenta previa pregnancies at Department of Obstetrics, Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan, since January 2016 till December 2016, after approval of the study protocol by the Local Ethical Committee.

All participants have complete placenta previa and provide written informed consent to undergo any procedure necessary as an attempt to avoid hysterectomy. And they also provide written informed consent to undergo hysterectomy if all measures attempted to preserve the uterus fail.

To precisely determine the placental location and the edge of the placenta, preoperative ultrasonography is used in determining the optimal place for the uterine incision. The investigator performed all cesarean deliveries and assisted by the second investigator. The parietal peritoneum is opened by sharp dissection and blunt expansion, if necessary, high above the bladder, a bladder flap is made and the bladder is retracted. A random hysterotomy incision is done in the placenta margin. It is expanded on both sides using scissors, stopping shortly before the uterine arteries. Active delivery of the placenta is attempted by searching manually for a plane of cleavage between the placenta and the uterus after delivery of the fetus. In addition to uterotonics, measures such as "oversewing" of the placental bed, intrauterine balloon tamponade, and B-Lynch or other compression sutures are also used depending on different circumstances.

02

Conditions studied

  • Complete Placenta Previa

Browse trials for

Keywords

  • Complete Placenta Previa
  • Random Placenta Margin Incision
  • Cesarean Section
  • Hemorrhage
03

In context

Placenta Previa

93 studies on the registry are indexed under Placenta Previa; 20 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 53 interventional studies indexed under Placenta Previa.

Browse Placenta Previa studies →

Lead sponsor

Maternal and Child Health Hospital of Foshan is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • A gestation age of ≥ 28 weeks
  • Delivered by cesarean section
  • Antepartum diagnosis of complete placenta accreta by obstetric ultrasound and doppler

Exclusion criteria

Exclusion Criteria:

  • Women who refuse to participate
  • Pregnant women with serious diseases
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    All Participants

    A random hysterotomy incision is done in the placenta margin. To precisely determine the placental location and the edge of the placenta, preoperative ultrasonography is used in determining the optimal place for the uterine incision.

    Procedure: Random Placenta Margin Incision

Interventions

  • ProcedureRandom Placenta Margin Incision

    A random hysterotomy incision is done in the placenta margin. To precisely determine the placental location and the edge of the placenta, preoperative ultrasonography is used in determining the optimal place for the uterine incision.

06

What researchers measure

Primary outcomes

  1. Postpartum Hemorrhage

    Time frame: within the first 30 days after cesarean section

Secondary outcomes

  1. Number of blood products transfused

    Time frame: within the first 30 days after cesarean section

  2. Length of hospitalization

    Time frame: 6 months after delivery

07

Study locations

1 site
  • Maternal and Child Health Hospital of Foshan
    Foshan, Guangdong 528000, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02695069
Lead sponsor
Maternal and Child Health Hospital of Foshan
Responsible party
Zhengping Liu, MD (Director, Maternal and Child Health Hospital of Foshan) — Principal investigator
First posted
Mar 1, 2016
Start date
Jan 2016
Primary completion
Mar 2017
Completion
Apr 2017
Last update
Nov 13, 2017

Study contacts

Zhengping Liu, MD
principal investigator · Maternal and Child Health Hospital of Foshan

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion